首页> 外文期刊>European Journal of Obstetrics, Gynecology and Reproductive Biology: An International Journal >Twin pregnancy with complete hydatidiform mole and coexistent fetus: obstetrical and oncological outcomes in a series of 14 cases.
【24h】

Twin pregnancy with complete hydatidiform mole and coexistent fetus: obstetrical and oncological outcomes in a series of 14 cases.

机译:双胎妊娠伴葡萄胎完全葡萄胎并存胎儿:14例产科和肿瘤学结局。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Twin pregnancy with complete hydatidiform mole and coexistent fetus (CHM&CF) is a rare situation and a challenge for diagnosis. Results related to fetal outcome and maternal risk of subsequent gestational trophoblastic neoplasia (GTN) are controversial. We here display a series from the French Trophoblastic Disease Reference Center, which is to date the third in number of cases registered by the same center. STUDY DESIGN: By retrospective method based on patients from the French Trophoblastic Disease Reference Center data base between November 1999 and December 2006, 17 assumed cases were reviewed. In 14 cases the diagnosis of CHM&CF was ascertained. All files were reviewed to confirm diagnosis. Methods of initial diagnosis, outcome of pregnancy and evolution to GTN were studied. RESULTS: In 10 cases (71%) diagnosis was made by ultrasonography. Differential diagnoses were partial hydatidiform mole and mesenchymal dysplasia. Three patients in 14 (21%) delivered a healthy child. In only one case, delivery occurred after 37 weeks of gestation. Seven patients (50%) had a diagnosis of GTN. No patient had fatal evolution. Clinical events, such as vaginal bleeding, pre-eclampsia or hyperthyroidism, had no effect on the evolution to GTN. Continuation of the pregnancy did not increase the risk of GTN. CONCLUSION: In case of prenatal diagnosis of CHM&CF, and even if delivery of a healthy child is possible, patients should be aware of a possibly higher risk of GTN than in CHM.
机译:目的:双胎妊娠伴葡萄胎完全葡萄胎和胎儿并存(CHM&CF)是一种罕见的情况,也是诊断的挑战。与胎儿结局和随后的妊娠滋养细胞瘤形成(GTN)的母亲风险有关的结果是有争议的。我们在这里展示了来自法国滋养细胞疾病参考中心的一系列报道,这是迄今为止该中心登记的病例数的第三位。研究设计:采用回顾性方法,根据1999年11月至2006年12月间法国滋养细胞疾病参考中心数据库中的患者,回顾了17例假设病例。在14例中,确定了CHM&CF的诊断。检查所有文件以确认诊断。研究了初步诊断,妊娠结局和向GTN演变的方法。结果:10例(71%)通过超声检查诊断。鉴别诊断为部分葡萄胎和间充质增生。 14例中有3例(21%)分娩了一个健康的孩子。仅在一种情况下,分娩在妊娠37周后发生。七名患者(50%)被诊断为GTN。没有患者发生致命的进化。阴道出血,先兆子痫或甲状腺功能亢进等临床事件对向GTN的演变没有影响。继续妊娠并没有增加GTN的风险。结论:在产前诊断为CHM&CF的情况下,即使可以分娩健康的孩子,患者也应意识到GTN的风险可能比CHM高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号